Last reviewed · How we verify

Local infiltration analgesia

Medical University of Graz · Phase 3 active Small molecule

Local infiltration analgesia delivers anesthetic agents directly into surgical tissue planes to block pain signals at the site of injury.

Local infiltration analgesia delivers anesthetic agents directly into surgical tissue planes to block pain signals at the site of injury. Used for Postoperative pain management in surgical patients, Acute pain relief following surgical procedures.

At a glance

Generic nameLocal infiltration analgesia
Also known asdexmedetomidine, Ropivacaine
SponsorMedical University of Graz
Drug classLocal anesthetic
ModalitySmall molecule
Therapeutic areaPain Management / Anesthesia
PhasePhase 3

Mechanism of action

This technique involves injecting local anesthetic solutions (such as liposomal bupivacaine or other local anesthetics) directly into the surgical wound or tissue planes during or after surgery. The anesthetic diffuses through the tissue to block nerve conduction and provide prolonged postoperative pain relief at the surgical site, reducing the need for systemic opioids.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results